–(BUSINESS WIRE)–Iris Pharma is an independent Contract Research Organization (CRO), dedicated to preclinical and clinical research in ophthalmology.
Category: Clinical Trials
Creation of the Biobank Related to Eye Disease
Status: Recruiting,
Condition Summary: Eye Diseases
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
Status: Not yet recruiting,
Condition Summary: Dry Eye
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Recruiting,
Condition Summary: Macular Degeneration; Age-Related Maculopathies; Age-Related Maculopathy; Maculopathies, Age-Related; Maculopathy, Age-Related; Retinal Degeneration; Retinal Neovascularization; Gene Therapy; Therapy, Gene; Eye D…
Trial of CF101 to Treat Patients With Dry Eye Disease
Status: Not yet recruiting,
Condition Summary: Dry Eye Disease
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
Status: Recruiting,
Condition Summary: Dry Eye Syndromes
Manifestations of Heritable Disorders of Connective Tissue
Status: Recruiting,
Condition Summary: Ehlers-Danlos Syndrome; Marfan Syndrome; Stickler Syndrome
Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Status: Active, not recruiting,
Condition Summary: Age-Related Macular Degeneration; Wet Age-Related Macular Degeneration; Macular Degeneration; Eye Diseases; Retinal Diseases
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Status: Recruiting,
Condition Summary: Age-Related Maculopathy; Age-Related Maculopathies; Eye Diseases; Retinal Degeneration; Macular Degeneration
Repository for Inherited Eye Diseases
Status: Recruiting,
Condition Summary: Retinitis Pigmentosa; Inherited Ophthalmic Diseases
Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE 2)
Status: Recruiting,
Condition Summary: Ischemia; Retinal Vein Occlusion; Pathologic Processes; Retinal Diseases; Eye Diseases
Safety & Efficacy Study of the IRay System in Patients With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Status: Recruiting,
Condition Summary: AMD; Wet AMD; Age-Related Macular Degeneration; Wet Age-Related Macular Degeneration; Macular Degeneration; Eye Diseases; Retinal Diseases
Study of Sentinel Lymph Node Biopsy for Conjunctival Melanoma and Sebaceous Cell Carcinoma of the Eyelid
Status: Recruiting,
Condition Summary: Eye Disease; Melanoma
Evaluation and Treatment of People With Eye Diseases
Status: Recruiting,
Condition Summary: Eye Diseases
A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Status: Recruiting,
Condition Summary: Graves Ophthalmopathy
Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)
Status: Recruiting,
Condition Summary: Thyroid-Related Eye Disease
Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases
Status: Recruiting,
Condition Summary: Eye Diseases
Tissue Studies of Human Eye Diseases
Status: Recruiting,
Condition Summary: Conjunctival Disease; Corneal Disease; Eye Disease; Uveitis; Vitreoretinopathy, Proliferative
Screening for Research Participants
Status: Recruiting,
Condition Summary: Eye Diseases